Biological Material Analysis TRIZ Cases

Paired antibodies targeting distinct epitopes on the SARS-CoV-2 nucleocapsid protein enhance detection specificity and lower the limit of detection.

VHH domain antibodies bind the IL-2 receptor complex to selectively stimulate regulatory T cells, resolving specificity and half-life trade-offs.

Distinct epitope antibodies quantify shed FOLR1 in patient samples, eliminating competitive inhibition from concurrent huMov19 therapy.

Anti-GAG motif antibodies bind specific cell surface glycans to identify and isolate distinct cellular phenotypes.

Conjugating the galactose-alpha-1,3-galactose epitope to a macromolecule carrier isolates specific IgE levels from general immune responses.

Dual control thresholds compare signals at distinct times to extend dynamic range and reduce hook effect errors.

Rv2626c-derived peptide composition differentiates latent from active tuberculosis by measuring interferon-gamma levels in peripheral blood mononuclear cells.

Distributed microfluidic channels shift bioreagent transport from diffusion to advection, reducing immunohistochemistry processing time from hours to minutes.

Fluorescent labeling of intracellular receptors enables automated optical detection through flow cytometry for rapid cell analysis.

Monoclonal antibody 2E7 detects muramyl peptides via picomolar affinity, overcoming low specificity limits of existing antibodies.

Antibodies 22C3 and 20C3 detect human PD-L1 expression in FFPE tissue, resolving low specificity of prior antibodies.

FLNA binding antibodies detect filamin A to distinguish aggressive from non-aggressive prostate cancer, improving diagnostic accuracy beyond PSA limitations.

Chemically modified antibiotics target mitochondria to inhibit biogenesis, eradicating resistant cancer stem cells that survive conventional therapies.

Grafted CDR sequences in humanized anti-CD47 antibodies block CD47-SIRPα interactions to promote tumor cell phagocytosis without erythrocyte agglutination.

Segmented immunoassay detects Mx-B and CRP markers simultaneously, reducing antibiotic misuse.

Secondary moiety co-deposition enables kinetic differential drift correction for frequency-insensitive aptamer sensors in whole blood.

Composite affinity column with monoclonal antibodies purifies five mycotoxins, eliminating solvent interference for accurate LC-MS quantification.